I-FABP Activators

The class of I-FABP Activators includes various compounds that indirectly influence the activity of I-FABP, primarily through modulation of lipid metabolism and fatty acid transport within enterocytes. These activators increase the availability or demand for fatty acids in intestinal cells, thereby potentially enhancing the transport activity of I-FABP. Fatty acids such as oleic acid, linoleic acid, palmitic acid, eicosapentaenoic acid (from fish oil), and conjugated linoleic acid are substrates for I-FABP. Their increased presence in the intestinal lumen can stimulate I-FABP activity as these fatty acids are bound and transported by I-FABP within the cells. Additionally, compounds that modulate lipid metabolism, such as PPAR agonists (rosiglitazone, pioglitazone, fenofibrate, bezafibrate), can indirectly influence I-FABP activity by altering the lipid handling dynamics in enterocytes.

Furthermore, insulin and glucagon, which regulate overall lipid metabolism, can also influence the functional demand on I-FABP. Metformin can affect lipid metabolism pathways and thus may indirectly influence I-FABP activity. In summary, these compounds represent a diverse group capable of indirectly modulating the activity of I-FABP through their effects on lipid metabolism and fatty acid transport. By altering the availability of fatty acids and the regulatory environment of lipid metabolism, these compounds can enhance or influence the transport function of I-FABP, highlighting its role in intestinal fatty acid handling and metabolism.